Project Grant HT9425261E360
Award Date 8/1/26
Completion Date 7/31/29
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a Project Grant totaling $699,751 under the Military Medical Research and Development program (CFDA 12.420) for the period May 1, 2026 through April 30, 2029. The grant supports research titled "Unveiling Mechanisms and Innovative Therapies for ESR1-CCDC170 Fusions in Clinically Aggressive, Endocrine-Resistant and Metastatic Breast Cancers," to be conducted at the University's facilities in...
- Federal Grant Award Summary The Washington University was awarded $500,000 in Project Grant funding from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2027. The award supports research titled "Harnessing Single-Cell T Cell-Receptor Sequencing to Accelerate Diagnosis in Inflammatory Arthritis," to be conducted at the university's University City, Missouri campus. This research project...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- Federal Grant Award Summary The Washington University received a $155,500 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025, through September 30, 2027. The research project investigates LAT1 (L-type amino acid transporter 1) as a therapeutic and diagnostic marker in malignant peripheral nerve sheath tumors (MPNSTs). This two-year initiative supports hypothesis-driven biomedical research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University Office of Sponsored Research Services a Project Grant totaling $834,915 under the Military Medical Research and Development program (CFDA 12.420) to develop small molecules that disrupt TDP-43 (TAR DNA-binding protein 43) aggregation and restore protein function. The award, dated May 1, 2026, with an ultimate completion date of April 30, 2028, supports basic and applied biomedical research...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $256,208 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The grant supports research on deuterium metabolic imaging as a noninvasive diagnostic tool to measure metabolic reprogramming in glioblastoma, a severe form of brain cancer. This research aims to develop...
- Federal Project Grant Award Summary The Washington University received a $210,292 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award supports research into "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma," conducted at the university's Office of Sponsored Research Services in University City, Missouri....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $1,197,813 Project Grant to the University of California, San Diego on August 15, 2025, under the Military Medical Research and Development program (CFDA 12.420) for mechanism dissection and model development of human PD1 (Programmed Death receptor 1) in melanoma. The three-year award, with a completion date of August 14, 2028, supports basic and applied biomedical research investigating immunotherapeutic mechanisms relevant...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University Office of Sponsored Research Services a Project Grant of $840,000 under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2028. This award supports investigative research examining hyperphosphorylation of tau serine 262 as a novel biomarker and therapeutic target in amyotrophic lateral sclerosis (ALS). The research addresses the DHA's mission...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $447,625 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025, through May 31, 2028. This award supports research on refractive surgery for autism spectrum disorder (ASD), leveraging the university's established capabilities in advanced biomedical research and clinical investigation. The...